V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210038336 | 210008924 | null | null | Disease modification (D) | 2019-08-13 | 2019-08-14 | RIALTO TRIAL | N | N | 210016939 | ERWINIA ASPARAGINASE |
| 210038337 | 210009038 | 0 | 97 | Curative (C) | 2017-09-05 | 2017-09-06 | Erwinase (Erwinia Asparaginase) | 2 | N | 210017421 | RIALTO TRIAL |
| 210038338 | 210009377 | 1.61 | null | Adjuvant (A) | 2018-11-06 | 2019-02-14 | IDELALISIB | N | N | 210018518 | CHLORAMBUCIL + OFATUMUMAB |
| 210038339 | 210009736 | 0 | 79.2 | Curative (C) | 2017-12-03 | 2017-12-04 | CNS LGG 2004 03 vinc weekly+ carbo | 2 | N | 210019691 | CARBOPLATIN + VINCRISTINE |
| 210038340 | 210010256 | 1.67 | null | Curative (C) | 2015-01-22 | 2015-08-27 | Bevacizumab 15mg/kg | 02 | N | 210021606 | BEVACIZUMAB |
| 210038341 | 210036861 | null | null | Curative (C) | 2016-09-23 | 2016-10-03 | Cyclophosphamide + Vincristine | N | null | 210025775 | METHOTREXATE HIGH DOSE |
| 210038342 | 210010799 | 0 | null | Curative (C) | 2018-12-27 | 2018-12-27 | CHOP - 21 days | N | N | 210027027 | METHOTREXATE HIGH DOSE |
| 210038343 | 210010805 | null | 58.6 | Adjuvant (A) | 2017-04-03 | 2017-04-07 | Maintenance Therapy ALL | N | N | 210027036 | TAMIGA TRIAL |
| 210038344 | 210010876 | 1.69 | 66.5 | Curative (C) | 2017-04-05 | 2017-11-28 | Alemtuzumab + Cyclophos TBI Allo | 02 | N | 210027529 | IRINOTECAN + TEMOZOLOMIDE |
| 210038345 | 210012143 | 1.82 | 70.2 | Disease modification (D) | 2015-06-27 | 2015-10-04 | TRASTUZUMAB | N | null | 210033299 | CISPLATIN + LOMUSTINE + VINCRISTINE |
| 210038346 | 210012158 | 1.83 | 82.3 | Curative (C) | null | 2017-01-07 | CNS HGG HERBY Maint Temoz+Bev | 99 | Y | 210033375 | HERBY TRIAL |
| 210038347 | 210012304 | 1.79 | 10.9 | null | 2018-06-27 | 2018-07-06 | Cytarabine HD + Methotrexate HD | Y | N | 210034037 | VEDEX |
| 210038348 | 210012320 | 1.6 | 47.9 | Curative (C) | 2017-08-17 | 2018-08-02 | Cyclophos + Dex + Lenalidomide | N | N | 210034115 | ICE |
| 210038349 | 210021836 | 1.6 | 91.65 | Curative (C) | 2019-06-10 | 2019-12-09 | DOXORUBICIN | N | N | 210034234 | CYTARABINE INTRATHECAL |
| 210038350 | 210027729 | 1.74 | 76 | Curative (C) | 2020-10-10 | 2020-10-31 | Cyclophosphamide High Dose | N | N | 210034702 | CISPLATIN + LOMUSTINE + VINCRISTINE |
| 210038351 | 210012788 | 0 | null | Curative (C) | 2014-07-06 | 2014-11-14 | PACLITAXEL | N | N | 210037370 | CLADRIBINE + RITUXIMAB |
| 210038352 | 210027877 | 1.76 | 94.2 | Curative (C) | 2017-12-15 | 2018-10-07 | CLL210 TRIAL | N | N | 210037617 | MITOMYCIN |
| 210038353 | 210012986 | null | null | Curative (C) | 2016-09-21 | 2017-06-14 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | 210038312 | FLUDARABINE + MELPHALAN |
| 210038354 | 210013148 | null | 87.6 | Palliative (P) | 2020-11-03 | 2020-11-10 | CLARITY Trial | 02 | N | 210039036 | ABIRATERONE |
| 210038355 | 210028053 | 1.58 | 11.4 | Disease modification (D) | 2018-07-12 | 2019-01-20 | BUSULFAN + FLUDARABINE + METHOTREXATE | N | N | 210040628 | ALL INDUCTION |
| 210038356 | 210013495 | null | 61.8 | Curative (C) | 2016-05-06 | 2016-05-06 | PACLITAXEL | N | N | 210041021 | ALL INTENSIFICATION MTX |
| 210038357 | 210022532 | 1.72 | 85.6 | Curative (C) | 2019-04-11 | 2019-05-30 | Pemetrexed | Y | N | 210042069 | UKALL2003 |
| 210038358 | 210022610 | 1.69 | 76 | Disease modification (D) | 2019-09-01 | 2019-09-11 | CARBO + ETOPOSIDE + VINCRISTINE | N | N | 210028705 | IVE-R |
| 210038359 | 210014054 | 1.63 | 87.4 | Curative (C) | 2017-08-05 | 2020-06-11 | CVP | Y | N | 210041781 | BEVACIZUMAB + TEMOZOLOMIDE |
| 210038360 | 210004305 | 1.65 | null | Not known (9) | 2015-05-28 | 2015-10-16 | Temozolomide 200mg/m2 | N | N | 210000122 | TEMOZOLOMIDE |
| 210038363 | 210004761 | 0 | 73.7 | Curative (C) | 2018-12-24 | 2019-04-08 | Temozolomide 150mg/m2 | N | Y | 210002776 | TEMOZOLOMIDE |
| 210038364 | 210017530 | 1.77 | null | Curative (C) | 2018-05-20 | 2018-06-11 | TEMOZOLOMIDE | 02 | N | 210004002 | TEMOZOLOMIDE |
| 210038365 | 210005063 | 1.75 | 76 | Curative (C) | 2018-07-20 | 2018-10-06 | Temozolomide 200mg/m2 | N | N | 210004402 | TEMOZOLOMIDE |
| 210038366 | 210017578 | 1.75 | 69.7 | Palliative (P) | 2015-04-06 | 2015-04-07 | TEMOZOLOMIDE | 02 | N | 210004493 | TEMOZOLOMIDE |
| 210038367 | 210017581 | 0 | 51.3 | Palliative (P) | 2017-05-12 | 2017-06-14 | Temozolomide 200mg/m2 | N | N | 210004496 | TEMOZOLOMIDE |
| 210038368 | 210029670 | null | 62.5 | Palliative (P) | 2016-06-11 | 2018-04-01 | Temozolomide 200mg/m2 | N | N | 210004715 | TEMOZOLOMIDE |
| 210038369 | 210032632 | 0 | 61.6 | Curative (C) | 2017-05-11 | 2017-08-22 | Temozolomide 150mg/m2 | N | Y | 210004847 | TEMOZOLOMIDE |
| 210038370 | 210005178 | 1.88 | 55 | Curative (C) | 2017-11-27 | 2018-08-29 | ALL UKALL2011 Maintenance A1 | 1 | N | 210005122 | UKALL2011 |
| 210038371 | 210017633 | null | 64.1 | Curative (C) | 2014-04-07 | 2014-11-02 | ALL UKALL2011 Del Int C Recon PAsp | Y | N | 210005131 | UKALL2011 |
| 210038372 | 210025022 | 1.82 | 15 | Curative (C) | 2014-11-24 | 2015-06-06 | ALL UKALL2011 Del Int C Recon PAsp | Y | N | 210005198 | UKALL2011 |
| 210038373 | 210005237 | null | 22.2 | Curative (C) | 2015-01-17 | 2015-07-04 | ALL UKALL2011 Maintenance A1 | Y | N | 210005293 | UKALL2011 |
| 210038374 | 210017661 | null | 92.7 | Curative (C) | 2018-08-13 | 2018-08-20 | ALL UKALL2011 Maintenance A1 | Y | N | 210005410 | UKALL2011 |
| 210038376 | 210017670 | 0 | null | Curative (C) | 2018-03-16 | 2018-05-12 | ALL UKALL2011 Maintenance C1 | Y | null | 210005470 | UKALL2011 |
| 210038378 | 210017685 | 1.85 | 20 | Curative (C) | 2018-03-08 | 2018-03-08 | ALL UKALL2011 Cap Int Maint C PAsp | Y | N | 210005614 | UKALL2011 |
| 210038379 | 210017741 | null | null | Curative (C) | 2015-04-01 | 2015-10-29 | ALL UKALL2011 Maintenance A1 | Y | N | 210006133 | UKALL2011 |
| 210038380 | 210034609 | null | 17.5 | Curative (C) | 2017-06-04 | 2017-10-24 | ALL UKALL2011 Maintenance B4 | Y | N | 210006371 | UKALL2011 |
| 210038381 | 210025153 | null | null | Curative (C) | 2019-05-26 | 2019-08-02 | ALL UKALL2011 Del Int A Pt1 (PAsp) | Y | null | 210006587 | UKALL2011 |
| 210038382 | 210017794 | 0 | 21.9 | Curative (C) | 2015-09-17 | 2016-07-17 | ALL UKALL2011 Maintenance A1 | Y | N | 210006602 | UKALL2011 |
| 210038383 | 210005560 | null | 32.8 | Curative (C) | 2012-09-26 | 2014-08-22 | ALL UKALL2011 Maintenance A1 | Y | N | 210006736 | UKALL2011 |
| 210038384 | 210005574 | 1.82 | 21.1 | Palliative (P) | 2016-01-31 | 2016-08-15 | ALL UKALL2011 Maintenance A3 | N | N | 210006824 | UKALL2011 |
| 210038385 | 210005580 | 1.64 | 24.7 | Curative (C) | 2020-06-03 | 2020-06-09 | ALL UKALL2011 Aug BFM Cons C PegAsp | Y | null | 210006833 | UKALL2011 |
| 210038386 | 210005602 | null | 104.95 | Curative (C) | 2019-10-12 | 2019-12-10 | ALL UKALL2011 Del Int A Pt1 (PAsp) | Y | Y | 210006940 | UKALL2011 |
| 210038388 | 210005640 | null | 18.15 | Curative (C) | 2016-12-07 | 2017-04-25 | ALL UKALL2011 Cap Int Maint C PAsp | 2 | N | 210007091 | UKALL2011 |
| 210038389 | 210005653 | 1.12 | 73.9 | Curative (C) | 2014-08-21 | 2015-01-30 | ALL UKALL2011 Del Int A Pt1 (PAsp) | Y | N | 210007149 | UKALL2011 |
| 210038390 | 210005673 | null | 16.1 | Curative (C) | 2016-01-05 | 2016-05-22 | ALL UKALL2011 Del Int A Pt1 (PAsp) | 01 | N | 210007259 | UKALL2011 |